Healthcare news and intelligence for Southern Africa
Daily reporting for the pharmaceutical, medical scheme and hospital sectors, published by Health Matters since 1994.
10 October 2026
JSE healthcare shares gain as Aspen cuts debt and hospitals improve margins. Explore the growth drivers and risks facing the sector.
Latest
8 October 2026
8 October 2026
8 October 2026
6 October 2026
6 October 2026
5 October 2026
More news
16 October 2024
Massive investment in human resources, interdisciplinary training, and public-private integration is essential to achieving equity and access under NHI.
16 October 2024
The key factors driving the 2025 medical scheme contribution hikes in South Africa include medical inflation and chronic disease prevalence.
15 October 2024
South Africa's HIV prevention pill programme leads globally with 1.65M users by August 2024, aiming to reduce new infections and meet UNAIDS targets by 2025.
15 October 2024
New studies confirm the effectiveness of a six-month HIV prevention injection, showing remarkable results in reducing infections across diverse populations.
14 October 2024
Unpacking the governance crisis at Bonitas Medical Fund - concerns rise over trustees' decisions and potential conflicts of interest.
14 October 2024
Lessons from the COVID-19 pandemic can guide South Africa's National Health Insurance (NHI) towards achieving health equity for all citizens.
11 October 2024
The final report from the investigation into racial profiling in medical schemes is delayed. The report investigated discrimination in medical aid processes.
11 October 2024
Health Minister Aaron Motsoaledi addresses the shortfall in community service posts for medical graduates by converting surplus posts in other healthcare areas.
11 October 2024
Learn how transforming vaccine manufacture in Africa aims to enhance self-sufficiency and ensure better healthcare access for all.
11 October 2024
Pepfar head John Nkengasong urges US Congress to return to a five-year reauthorisation of HIV/AIDS relief funding for countries like South Africa.
10 October 2024
Eli Lilly is betting on weight-loss drugs like Mounjaro, but can it overcome production challenges to become the first trillion-dollar pharmaceutical company?
9 October 2024
COVID vaccination rates remain low, with less than 5% of US adults receiving the latest shot. Convenience and cost are impacting uptake and potential solutions.
The archive
Browse every Health Matters article by month.